Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Holt

Showing results (151-160 of 244) with videos related to

Pageof 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stabilityD L Tait, P S Obermiller, A R Hatmaker, et al.
Nature Genetics|April 1, 1995
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progressionM E Thompson, R A Jensen, P S Obermiller, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
Fumonisins and Alternaria alternata lycopersici toxins: sphinganine analog mycotoxins induce apoptosis in monkey kidney cellsW Wang, C Jones, J Ciacci-Zanella, et al.
The Journal of Hospital Infection|June 12, 2021
How dirty is which QWERTY?C P Haanappel, A F Voor In 't Holt, J A Severin, et al.
Pharmacology|December 18, 2017
Using Controlled Substance Receipt Patterns to Predict Prescription Overdose DeathChristina T Holt, Kenneth L McCall, Gary Cattabriga, et al.
Studies in Health Technology and Informatics|December 2, 2024
Creating Synergy: The Partnership Between Infection Prevention & Control Architectural Design for a Healthier HospitalMargreet C Vos, Anne F Voor In 't Holt, Juliëtte A Severin, et al.
Epidemiology and Infection|December 16, 2000
UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from EuropeB Hanratty, T Holt, E Duffell, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2014
A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosaAnne F Voor In 't Holt, Juliëtte A Severin, Emmanuel M E H Lesaffre, et al.
Breast Disease|February 3, 2005
Gene therapy for breast and ovarian cancer with BRCA1D L Tait, R A Jensen, J T Holt, et al.
The Journal of Biological Chemistry|June 22, 1999
BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repairD W Abbott, M E Thompson, C Robinson-Benion, et al.
Pageof 25

Showing results (151-160 of 244) with videos related to

Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stabilityD L Tait, P S Obermiller, A R Hatmaker, et al.
Nature Genetics|April 1, 1995
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progressionM E Thompson, R A Jensen, P S Obermiller, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
Fumonisins and Alternaria alternata lycopersici toxins: sphinganine analog mycotoxins induce apoptosis in monkey kidney cellsW Wang, C Jones, J Ciacci-Zanella, et al.
The Journal of Hospital Infection|June 12, 2021
How dirty is which QWERTY?C P Haanappel, A F Voor In 't Holt, J A Severin, et al.
Pharmacology|December 18, 2017
Using Controlled Substance Receipt Patterns to Predict Prescription Overdose DeathChristina T Holt, Kenneth L McCall, Gary Cattabriga, et al.
Studies in Health Technology and Informatics|December 2, 2024
Creating Synergy: The Partnership Between Infection Prevention & Control Architectural Design for a Healthier HospitalMargreet C Vos, Anne F Voor In 't Holt, Juliëtte A Severin, et al.
Epidemiology and Infection|December 16, 2000
UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from EuropeB Hanratty, T Holt, E Duffell, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2014
A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosaAnne F Voor In 't Holt, Juliëtte A Severin, Emmanuel M E H Lesaffre, et al.
Breast Disease|February 3, 2005
Gene therapy for breast and ovarian cancer with BRCA1D L Tait, R A Jensen, J T Holt, et al.
The Journal of Biological Chemistry|June 22, 1999
BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repairD W Abbott, M E Thompson, C Robinson-Benion, et al.
Pageof 25